Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
You are being asked to volunteer for a research study. You are being asked to participate in
this study because you have completed at least one month of drug treatment with a nasal
steroid and allergy testing and still have symptoms. This research study is sponsored by
NeilMed Pharmaceuticals, Inc. The purpose of this study is to compare quality of life
outcomes in patients who continue medical treatment plus the use of the NeilMed Sinus Rinse
low-pressure pump with saline. Your participation in this study may help to improve the
management of patients with allergic rhinitis.
Allergic rhinitis is a common health problem, affecting between 10% and 40% of the world's
population. Presently, antihistamines and nasal steroids are the standard treatment for
allergic rhinitis. To further clarify these findings, we propose a study comparing the
differences in quality of life improvements, by using a series of questionnaires, between
subjects electing continued medical management and those electing medical treatment plus
nasal wash.
The investigators in charge of the study are Dr. Rodney J. Schlosser and Dr. Shaun A. Nguyen.
Approximately 40 patients will be enrolled in this study at the Medical University of South
Carolina (MUSC Hospital). You will have the choice of choosing either to receive only medical
treatment or to receive medical treatment with nasal wash.